APA

Blom M., Kievit W., Kuper H. H., Jansen T. L., Visser H., den Broeder A. A., Brus H. L. M., van de Laar M. A. F. J. & van Riel P. L. C. M. (20101019). Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice. : Arthritis care & research.

Chicago

Blom M, Kievit W, Kuper H H, Jansen T L, Visser H, den Broeder A A, Brus H L M, van de Laar M A F J and van Riel P L C M. 20101019. Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice. : Arthritis care & research.

Harvard

Blom M., Kievit W., Kuper H. H., Jansen T. L., Visser H., den Broeder A. A., Brus H. L. M., van de Laar M. A. F. J. and van Riel P. L. C. M. (20101019). Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice. : Arthritis care & research.

MLA

Blom M, Kievit W, Kuper H H, Jansen T L, Visser H, den Broeder A A, Brus H L M, van de Laar M A F J and van Riel P L C M. Frequency and effectiveness of dose increase of adalimumab, etanercept, and infliximab in daily clinical practice. : Arthritis care & research. 20101019.